Literature DB >> 20409884

Estimated prevalence of uncontrolled hypertension and multiple cardiovascular risk factors and their associated risk of coronary heart disease in the United States.

Joshua S Benner1, Timothy W Smith, Allison A Petrilla, David Klingman, Sangeeta Goel, Simon S K Tang, Nathan D Wong.   

Abstract

This study determined the prevalence of primary prevention patients aged 40 to 79 years with uncontrolled hypertension (HTN) and low/moderate cholesterol levels, and the clinical and economic consequences of their cardiovascular risk levels stratified by additional cardiovascular risk factors. Prevalence was estimated from the 1999 to 2002 National Health and Nutrition Examination Survey (NHANES) datasets. Framingham risk equations were used to calculate the 4-year risk of coronary heart disease (CHD). HTN and cholesterol levels were then statistically "controlled" to ideal levels and risks were recalculated. Prevalence of uncontrolled hypertension was 15.2 million cases (13.7%). Of those, 12.9 million (84.8%) had low/moderate cholesterol levels, and 2.2 million (16.7%) had >/=3 additional risk factors with no history of CHD. Nearly 200,000 coronary events are expected to occur within 4 years, incurring over $2.5 billion in direct medical costs. Statistical estimation suggests that 64% of 4-year risk was attributable to uncontrolled blood pressure and lipids. The large number and high cost of CHD events expected to occur within the next 4 years in primary prevention patients with uncontrolled hypertension and >/=3 additional risk factors justifies aggressive screening to ensure that these patients are identified and properly managed.

Entities:  

Year:  2008        PMID: 20409884     DOI: 10.1016/j.jash.2007.07.001

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  2 in total

1.  Prevalence of Cardiovascular Diseases Risk Factors among Jordanians.

Authors:  Wesam Alsaud; Mohammad J Tabbaa; Violet N Kasabri; Maysa F Suyagh; Muneer A Abu Alsamen; Hussain M Haddad; Anas O ALshweki
Journal:  J Saudi Heart Assoc       Date:  2020-08-03

2.  Evaluation of the in vivo antihypertensive effect and antioxidant activity of HL-7 and HL-10 peptide in mice.

Authors:  Zahra Setayesh-Mehr; Leila Vafadar Ghasemi; Ahmad Asoodeh
Journal:  Mol Biol Rep       Date:  2021-07-21       Impact factor: 2.316

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.